An emerging strategy for targeted therapy of pulmonary arterial hypertension: Vasodilation plus vascular remodeling inhibition

Drug Discovery Today - Tập 27 - Trang 1457-1463 - 2022
Liqing Hu1,2,3, Congke Zhao1,2,3, Zhuo Chen1,2,3, Gaoyun Hu1,2,3, Xiaohui Li4, Qianbin Li1,2,3
1Department of Medicinal Chemistry, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, Hunan, China
2Hunan Key Laboratory of Diagnostic and Therapeutic Drug Research for Chronic Diseases, Changsha 410013, Hunan, China
3Hunan Key Laboratory of Organ Fibrosis, Changsha 410013, Hunan, China
4Department of Pharmacology, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, Hunan, China

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Drug Discovery Today

Tập 27

1457-1463

Thông tin tác giả